Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 28;10(4):757-769.
doi: 10.14218/JCTH.2022.00147. Epub 2022 Apr 29.

Guidelines for the Management of Cholestatic Liver Diseases (2021)

Affiliations

Guidelines for the Management of Cholestatic Liver Diseases (2021)

Lungen Lu et al. J Clin Transl Hepatol. .

Abstract

In 2015, the Chinese Society of Hepatology and the Chinese Society of Gastroenterology issued a consensus statement on the diagnosis and management of cholestatic liver diseases. More clinical data on this topic have appeared during recent years. The Autoimmune Liver Disease Group of the Chinese Society of Hepatology organized an expert group to review recent evidence and provide an update to these previous guidelines. Herein, we provide 22 recommendations as a working reference for the management of cholestatic liver diseases by clinical practitioners.

Keywords: Cholestatic liver disease; Diagnosis; Practice guidelines; Therapeutics.

PubMed Disclaimer

Conflict of interest statement

LL has been an associate editor of Journal of Clinical and Translational Hepatology since 2013. HY has been an editorial board member of Journal of Clinical and Translational Hepatology since 2021. YH has been an editorial board member of Journal of Clinical and Translational Hepatology since 2013. LW and JJ have been an executive associate editor of Journal of Clinical and Translational Hepatology since 2021. The other authors have no conflict of interests related to this publication.

Figures

Fig. 1
Fig. 1. Location of injuries that lead to cholestatic liver disease.
BRIC, benign recurrent intra-hepatic cholestasis; ICP, intrahepatic cholestasis of pregnancy; IgG4-SC, IgG4-related sclerosing cholangitis; PBC, primary biliary cholangitis; PFIC, progressive familial intrahepatic cholestasis; PSC, primary sclerosing cholangitis; SSC, secondary sclerosing cholangitis.
Fig. 2
Fig. 2. Recommended procedures for diagnosis of cholestatic liver diseases.
ALP, alkaline phosphatase; AMA, anti-mitochondrial antibodies; ANA, antinuclear antibodies; ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic ultrasound; GGT, gamma-glutamyl transferase; IgG4, immunoglobulin G4; PSC, primary sclerosing cholangitis.

Similar articles

Cited by

References

    1. Kuntz K, Kuntz HD. Hepatology: Principles and Practice. 2nd ed. Heidelberg, Germany: Springer Medizin Verlag Heidelberg; 2006. pp. 227–242.
    1. Wu H, Chen C, Ziani S, Nelson LJ, Ávila MA, Nevzorova YA, et al. Fibrotic Events in the Progression of Cholestatic Liver Disease. Cells. 2021;10(5):1107. doi: 10.3390/cells10051107. - DOI - PMC - PubMed
    1. Chinese Medical Association of Hepatology, Gastroenterology, Chinese Medical Association Consensus on diagnosis and treatment of cholestatic liver disease (2015) Chinese Zhonghua Gan Zang Bing Za Zhi. 2015;23(12):924–933. doi: 10.3760/cma.j.issn.1007-3418.2015.12.004. - DOI - PubMed
    1. Sherlock S, Dooley J. Disease of the liver and biliary system. 11th ed. Oxford, England: Blackwell Publishing; 2002. pp. 219–240.
    1. European Association for the Study of the Liver EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237–267. doi: 10.1016/j.jhep.2009.04.009. - DOI - PubMed